Home / MissionIR Articles / DepoMed, Inc. (DEPO) to Present at the ROTH Capital Partners 24th Annual Conference

DepoMed, Inc. (DEPO) to Present at the ROTH Capital Partners 24th Annual Conference

DepoMed is a specialty pharmaceutical company focused on enhancing existing pharmaceutical products. DepoMed has advanced to market two products and has developed a pipeline with late-stage product opportunities for the treatment of common medical conditions. DepoMed’s products center on its Acuform™ delivery technology, a patented, polymer-based technology designed to optimize drug delivery through gastric retention. For more information visit the company’s Web site at www.depomedinc.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: